Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 11, 2021

Treatment With a Polypill of Quarter Doses of Blood Pressure Medicines vs Standard-Dose Monotherapy

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension (QUARTET): A Phase 3, Randomised, Double-Blind, Active-Controlled Trial
Lancet 2021 Aug 27;[EPub Ahead of Print], CK Chow, ER Atkins, GS Hillis, MR Nelson, CM Reid, MP Schlaich, P Hay, K Rogers, L Billot, M Burke, J Chalmers, B Neal, A Patel, T Usherwood, R Webster, A Rodgers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading